O'Shaughnessy Asset Management, LLC Dynavax Technologies Corp Transaction History

O'Shaughnessy Asset Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$10.73 - $12.58 $26,889 - $31,525	-2,506 Reduced 19.88%	10,102 $113,000
Q1 2024 May 13, 2024	SELL	$11.7 - $14.98 $82,836 - $106,058	-7,080 Reduced 35.96%	12,608 $156,000
Q4 2023 Feb 09, 2024	BUY	$13.09 - $14.98 $9,123 - $10,441	697 Added 3.67%	19,688 $275,000
Q3 2023 Nov 13, 2023	BUY	$12.64 - $14.99 $240,046 - $284,675	18,991 New	18,991 $280,000
Q4 2021 Feb 11, 2022	SELL	$13.17 - $20.94 $102,027 - $162,222	-7,747 Closed	0 $0
Q2 2021 Aug 09, 2021	BUY	$7.25 - $10.99 $51,873 - $78,633	7,155 Added 1208.61%	7,747 $76,000
Q2 2020 Aug 13, 2020	BUY	$2.94 - $9.1 $1,740 - $5,387	592 New	592 $5,000
Q1 2020 May 13, 2020	SELL	$2.27 - $6.2 $2,996 - $8,184	-1,320 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$3.46 - $6.93 $4,567 - $9,147	1,320 New	1,320 $8,000

273

130M

451K

203K

Ticker DVAX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 126,474,000
Market Cap $1.54B
Description
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...

Get notified when there are updates to the investment portfolio of O'Shaughnessy Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on O'Shaughnessy Asset Management, LLC with notifications on news.